BetaGlue Therapeutics
BetaGlue Therapeutics is a Healthcare & Life Sciences startup based in Italy, most recent round Series A, 1 tracked investor.
About BetaGlue Therapeutics
Based in Italy, BetaGlue Therapeutics is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
BetaGlue Therapeutics develops YntraDose, a Yttrium-90 microsphere interventional radiotherapeutic platform that delivers localized radiation directly into solid tumors, targeting cancers such as pancreatic and liver cancer. The company is clinical-stage and conducting multiple clinical trials for unresectable locally advanced pancreatic cancer.
Explore BetaGlue Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.